Efficacy and safety of 15 mA transcranial alternating current stimulation (tACS) in the therapy of treatment-resistant depression with increased inflammatory activity: Study protocol for a randomized, double-blind, sham-controlled trial

Xuguang An, Jin Zhang, Xiaofei Hou, Chenghao Yang · 2026

Read Efficacy and safety of 15 mA transcranial alternating current stimulation (tACS) in the therapy of treatment-resistant depression with increased inflammatory activity: Study protocol for a randomized, double-blind, sham-controlled trial by Xuguang An, Jin Zhang, Xiaofei Hou, Chenghao Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356611.txt.

Description

Xuguang An, Jin Zhang, Xiaofei Hou, and Chenghao Yang describe a planned clinical trial of brain stimulation for depression that has resisted standard treatment, published as a study protocol in 2026. The trial will enroll seventy patients whose blood tests show raised inflammation, and will test a strong form of alternating current stimulation applied through the scalp.

Half the patients will receive real stimulation for four weeks and half a sham version, with neither patients nor raters knowing which. The team will track depression scores, response and remission rates, brain wave changes, and safety signals such as abnormal heart or brain activity. If stimulation helps this inflamed subgroup, it would support matching depression treatments to biology rather than trial and error.

Catalog record

CREATORXuguang An, Jin Zhang, Xiaofei Hou, Chenghao Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40895
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0356611

Browse the full library · About the Tower of Babel